Drug treatment of hypertension in patients with other cardiovascular diseases

ACC Current Journal Review - Tập 5 - Trang 64-66 - 1996
Jay M. Sullivan1
1College of Medicine, Division of Cardiovascular Diseases, Memphis, Tennessee, USA

Tài liệu tham khảo

Joint National Committee on Detection Evaluation Treatment of High Blood Pressure, 1993, 153, 154 Shub, 1985, Selection of optimal drug therapy for the patient with angina pectoris, 60, 539 Furburg, 1995, Nifedipine drug-related increase in mortality in patients with coronary heart disease, Circulation, 92, 1326, 10.1161/01.CIR.92.5.1326 Fletcher, 1992, How far should blood pressure be lowered?, N Engl J Med, 326, 251, 10.1056/NEJM199201233260407 Cody, 1994, Comparing angiotensin-converting enzyme inhibitor trial results in patients with acute myocardial infarction, Arch Intern Med, 154, 2029, 10.1001/archinte.1994.00420180031004 Parmley, 1989, Pathophysiology and current therapy of congestive heart failure, J Am Coll Card, 12, 771, 10.1016/0735-1097(89)90215-5 ACC/AHA Task Force Report, 1995, Guidelines for the evaluation and management of heart failure, JACC, 26, 1376, 10.1016/0735-1097(95)00469-6 Williams, 1991, Significance of classifying antiarrhythmic actions since the cardiac arrhythmia suppression trial, J Clin Pharmacol, 31, 123, 10.1002/j.1552-4604.1991.tb03695.x Johnson, 1992, Racial differences in blood pressure response to increased forearm vascular resistance, Clin Pharmacol Ther, 41, 141A Fowlkes, 1995, Estrogens, blood pressure, and cardiovascular diseases, Cardiol Rev, 3, 106, 10.1097/00045415-199503000-00006